SCHEMBL7344989

SCHEMBL7344989

COc1ccccc1N1CCN(CCCCN2CCN(c3ccccc3)C2=O)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.64
HTR7 P34969 3/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
DRD2 P14416 4/20 0.61
DRD3 P35462 4/20 0.61
DRD5 P21918 1/20 0.61
ALDH1A1 P00352 3/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
ALOX12 P18054 1/20 0.60
ADRA1D P25100 1/20 0.60
ADRA1A P35348 1/20 0.60
ADRA1B P35368 1/20 0.60
HIF1A Q16665 1/20 0.60
HSD17B10 Q99714 1/20 0.60
DRD4 P21917 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343240 0.90 DRD2 (0.59) HTR1AHTR7MEN1KMT2ACYP1A2
SCHEMBL7351802 0.89 HTR1A (0.58) HTR1AHTR7DRD2DRD3ADRA1D
SCHEMBL6924599 0.86 ADRA1A (0.57) HTR1ADRD2DRD3ADRA1DADRA1A
SCHEMBL6924603 0.85 DRD3 (0.55) HTR1AHTR7DRD2DRD3ALDH1A1
SCHEMBL7068893 0.83 KCNH2 (0.64) HTR1AHTR7DRD2DRD3DRD5
SCHEMBL7346970 0.82 KCNH2 (0.67) HTR1AHTR7DRD2DRD3ADRA1A
SCHEMBL6926592 0.81 ADRA1A (0.52) HTR1ADRD2DRD3ALDH1A1ADRA1D
SCHEMBL7344855 0.81 DRD2 (0.63) HTR1AHTR7DRD2DRD3DRD5
SCHEMBL6926651 0.81 DRD2 (0.55) HTR1AHTR7DRD2DRD3ALDH1A1
SCHEMBL7355246 0.80 HTR1A (0.60) HTR1AHTR7DRD2DRD3ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5281594-A Dopamine antagonist, Parkinson's disease and drug addiction THE UPJOHN COMPANY (US) 1994-01-25 US claimed
EP-0536279-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1993-04-14 EP claimed
WO-1992000282-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1992-01-09 WO claimed
US-5281594-A Dopamine antagonist, Parkinson's disease and drug addiction THE UPJOHN COMPANY (US) 1994-01-25 US disclosed
US-5281594-A Dopamine antagonist, Parkinson's disease and drug addiction THE UPJOHN COMPANY (US) 1994-01-25 US disclosed
EP-0536279-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1993-04-14 EP disclosed
EP-0536279-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1993-04-14 EP disclosed
WO-1992000282-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1992-01-09 WO disclosed
WO-1992000282-A1 SUBSTITUTED 1-(ALKOXYPHENYL)PIPERAZINES WITH CNS AND ANTIHYPERTENSIVE ACTIVITY THE UPJOHN COMPANY (US) 1992-01-09 WO disclosed